In 95% of 41 AML samples, AML cells from the CD34+TMIGD2+ subset expressed at least one of the CD45RA, CD123 and IL1RAP markers (Supplementary Fig. 1e). Here, TMIGD2 is linked to acute myeloid leukemia.